StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Regeneron Pharma (REGN) PT Raised to $352 at BMO Capital
November 5, 2019 3:43 PM
BMO Capital analyst Matthew Luchini raised the price target on Regeneron Pharma (NASDAQ: REGN) to $352.00 (from $344.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Regeneron Pharma (REGN) PT Raised to $352 at Cowen
November 5, 2019 3:42 PM
Regeneron Pharma (REGN) PT Raised to $340 at Canaccord Genuity
November 5, 2019 1:56 PM
Regeneron (REGN) Reports Updates on Phase 3 Libtayo (cemiplimab) Development Program in Advanced NSCLC
November 5, 2019 6:44 AM
Regeneron (REGN) Tops Q3 EPS by 31c, Offers FY Guidance
November 5, 2019 6:32 AM